Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

What’s in a disease name, anyway? Everything.

Jay Wong
Conditions
April 14, 2020
Share
Tweet
Share

Spanish Flu. Japanese Encephalitis. Middle Eastern Respiratory Syndrome. West Nile Virus. Wuhan Virus (and lately, the “Chinese Virus” as many have begun calling the pathogen that causes COVID-19: SARS-CoV-2).

What do these names all have in common, you might ask? Well, for one thing, they were constructed not by a strict scientific nomenclature, but by an aspect of the virus or disease that is inextricably linked to a facet of one’s ethnicity or geography. But more importantly, the nexus of commonality is their potential risk of fomenting stigmatization (or amplifying pre-existing stigma) towards the people or region associated with the pathogen and illness, an admonition that came straight from the World Health Organization.

In recent weeks, there has been a witnessing of public reproach against the current president’s reference to SARS-CoV-2 as the “Chinese Virus,” many concerned that it is an insidious dog whistle for his political base aimed at stoking the flames of xenophobia and deepening the Sino-American schism that is currently at the peak of political fragility. When the World Health Organization asserted that viruses like SARS-CoV-2 know no borders and do not care about our ethnicities, the president of the United States doubled down on his actions, justifying the phrase’s use on the grounds that he was merely stating an unassailable truth: that the novel coronavirus of 2019 originated from China. This then led to a second wave of public censure denouncing his, what many believed to be, coded us-vs-them rhetoric.

What is interesting though is that not long after this latest salvo of condemnation was launched against the president, a phalanx of his supporters from across the internet came out in a recriminatory fashion, staunchly declaring hypocrisy by citing a myriad of historical instances where viruses and diseases were named based on the location of its putative genesis or discovery, or named after a group of people it primarily afflicted without having ever received similar degrees of widespread excoriation in its aftermath, as in the cases mentioned at the beginning of this article and many others (e.g., Lyme Disease [named after a small coastal town in Connecticut called “Old Lyme”], Zika Virus [named after the Zika Forest in Uganda], and Ebola [named after the Ebola River in the Democratic Republic of Congo]). To many of his supporters, they saw an inconsistency here.

And just like that, the bloody war of names had erupted.

It occurred to me then to inquire more deeply, “What exactly about the phrase ‘Chinese Virus’ is racist?” Is it rooted in a subconsciously-driven uncharitable appraisal of the current president’s intentions based on the perception that he could only have a nefarious motivation to use this phrase due to his controversial track record and perceived personal character? Alternatively, is it the idiosyncratic synergy of the multi-racial/multi-ethnic composition of this country, the historically discriminatory treatment of Chinese populations in America, and the current acrimony-laced relations between the U.S. and China that makes a phrase like “Chinese Virus” contextually unpalatable, culturally tone-deaf, and racially insensitive? Or perhaps is it that the social landscape and cultural contours of our time have shifted and evolved in such a way that any ascription of a scourge such as a disease, illness, or microbial pathogen, even, to any location or group of people has become ineluctably linked to stigma transference to all associated person(s) as a matter of course? And to avoid a false trichotomy, is it all-together something else?

What exactly is the diagnostic calculus deployed then for determining whether a particular phrase or name ought to be amended due to its potentially detrimental impact on a society? And how can we more aptly explain to those who simply cannot see or understand how “Chinese Virus” can be precarious and stigmatizing when there are countless other extant examples that, to many, suggest this latest national outcry is all just part of a larger political subterfuge manufactured by the president’s adversaries to besmirch his character and stymie his re-election?

Given that a nuanced, all-encompassing discussion of this contentious topic would likely yield a panoply of opinions with multiple gradations of complexity and subjectivity, and that ultimately there would still likely remain a subset of the population who are immutable in their conviction that eponymous naming does not inherently carry any stigma or deleterious ramification, I propose a solution that may have the ability to put an end to this internecine semantics warfare once and for all.

The proposed solution? Obliterate the use of eponymous naming (past, present, and future) for all diseases, illnesses, and microbial pathogens, and instead, substitute in an equivalent counterpart constructed from an internationally standardized nomenclature that is entirely sterile (e.g., using medical terminology, dates, letters, numbers, etc.) and neutral (e.g., not referring to people, places, animals, food, plants, or anything that could be linked to a person’s identity such as culture, ethnicity, race, nationality, gender, sexual orientation, religion, physical appearance, age, disability, social status, etc.). Furthermore, perhaps we can redact current medical texts and as many eponymously named diseases and pathogens already in existence to reflect this change. This way, the precedent of eponymous naming can no longer be used as a justification by those who are not sympathetic to the plight of communities who are and have been harmed by such naming traditions. Additionally, it would further impugn the supposed benign intentions of proponents of eponymous naming by prompting us to ask them, “what is the compelling reason such that you absolutely must opt-in and elect eponymous naming when a very clear alternative with incontrovertible impartiality and objectivity exists?” which could more readily inculpate an ill-intentioned person feigning innocence in a crime of malicious will.

I do not suggest that such a solution (and an imperfect one at that) can happen overnight. But I do believe seemingly logistically complicated and initially unpopular changes like this one are, in fact, possible, if enough professionals in the medical community recognize its value and significance.

What’s in a name, anyway? Apparently … everything.

Jay Wong is a medical student. He received his undergraduate degree in molecular, cellular, and developmental biology from Yale University. He can be reached at his self-titled site, Jay Wong, and on Twitter @JayWongMedicine.

Image credit: Shutterstock.com

ADVERTISEMENT

Prev

How nurses made me a more compassionate and caring person, and a better physician

April 14, 2020 Kevin 1
…
Next

The shift from a junior to a senior resident

April 15, 2020 Kevin 0
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
How nurses made me a more compassionate and caring person, and a better physician
Next Post >
The shift from a junior to a senior resident

ADVERTISEMENT

More by Jay Wong

  • Ethical humanism: life after #medbikini and an approach to reimagining professionalism

    Jay Wong
  • The war on drugs: America’s secret racist war today

    Jay Wong
  • You’re outraged by police brutality and racism. OK, now what?

    Jay Wong

Related Posts

  • Should only infectious disease specialists be allowed to prescribe antibiotics?

    Craig Bowron, MD
  • What’s barbaric in medicine?

    Lisa Masson, MD, MBA
  • What’s wrong with crisis pregnancy centers?

    Nickey Jafari, MD
  • The culture of perfection in medicine is a disease

    Andy Cruz, MD
  • Chronic disease is making medical education worse

    Jason J. Han, MD
  • What’s the biggest problem with medical education?

    The Curious Radiologist, MD

More in Conditions

  • Remote second opinions for equitable cancer care

    Yousuf Zafar, MD
  • Why psychiatrists can’t treat family members

    Farid Sabet-Sharghi, MD
  • Aging parents and Thanksgiving: a gentle check-in

    Barbara Sparacino, MD
  • Trauma in high-functioning adults

    Ronke Lawal
  • Female athlete urine leakage: A urologist explains

    Martina Ambardjieva, MD, PhD
  • Funding autism treatments that actually work

    Ronald L. Lindsay, MD
  • Most Popular

  • Past Week

    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Remote second opinions for equitable cancer care

      Yousuf Zafar, MD | Conditions
    • Why young people need to care about bone health now

      Surgical Fitness Research Pod & Yoshihiro Katsuura, MD | Conditions
    • Why early diagnosis of memory loss is crucial

      Scott Tzorfas, MD | Conditions
    • The hidden epidemic of orthorexia nervosa

      Sally Daganzo, MD | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
  • Recent Posts

    • Remote second opinions for equitable cancer care

      Yousuf Zafar, MD | Conditions
    • How your past shapes the way you lead

      Brooke Buckley, MD, MBA | Physician
    • How private equity harms community hospitals

      Ruth E. Weissberger, MD | Physician
    • How culturally compassionate care builds trust and saves lives [PODCAST]

      The Podcast by KevinMD | Podcast
    • The U.S. health care crisis: a Titanic parallel

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD & Shreekant Vasudhev, MD | Physician
    • Why psychiatrists can’t treat family members

      Farid Sabet-Sharghi, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Remote second opinions for equitable cancer care

      Yousuf Zafar, MD | Conditions
    • Why young people need to care about bone health now

      Surgical Fitness Research Pod & Yoshihiro Katsuura, MD | Conditions
    • Why early diagnosis of memory loss is crucial

      Scott Tzorfas, MD | Conditions
    • The hidden epidemic of orthorexia nervosa

      Sally Daganzo, MD | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
  • Recent Posts

    • Remote second opinions for equitable cancer care

      Yousuf Zafar, MD | Conditions
    • How your past shapes the way you lead

      Brooke Buckley, MD, MBA | Physician
    • How private equity harms community hospitals

      Ruth E. Weissberger, MD | Physician
    • How culturally compassionate care builds trust and saves lives [PODCAST]

      The Podcast by KevinMD | Podcast
    • The U.S. health care crisis: a Titanic parallel

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD & Shreekant Vasudhev, MD | Physician
    • Why psychiatrists can’t treat family members

      Farid Sabet-Sharghi, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

What’s in a disease name, anyway? Everything.
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...